Therapeutic Polypeptides, Nucleic Acids Encoding Same, and Methods of Use

Details for Australian Patent Application No. 2009210387 (hide)

Owner CuraGen Corporation

Inventors Peyman, John A.; Ji, Weizhen; Rieger, Daniel K.; Anderson, David W.; Alvarez, Enrique; Zhong, Mei; Vernet, Corine A. M.; Crabtree-Boker, Julie R.; Boldog, Ferenc L.; Liu, Xiaohong; Sciore, Paul; Mishra, Vishnu S.; Guo, Xiaojia; Edinger, Shlomit R.; MacDougall, John R.; Ettenberg, Seth; Voss, Edward Z.; Shimkets, Richard A.; Zhong, Haihong; Millet, Isabelle; Rothenberg, Mark E.; Casman, Stacie J.; Spytek, Kimberley A.; Mezick, Amanda J.; Herrmann, John L.; Stone, David J.; Catterton, Elina; Li, Li; Alsobroo

Agent Cullen & Co

Pub. Number AU-A-2009210387

Parent 2003259027

Filing date 19 August 2009

Wipo publication date 10 September 2009

International Classifications

C12N 9/10 (2006.01) Enzymes, e.g. ligases (6.) - Transferases (2.)

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/36 (2006.01) Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

A61K 38/45 (2006.01) Medicinal preparations containing peptides

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/545 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 14/745 (2006.01) Peptides having more than 20 amino acids

C07K 14/775 (2006.01) Peptides having more than 20 amino acids

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/36 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/38 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against protease inhibitors of peptide structure

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C07K 16/42 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/25 (2006.01) Mutation or genetic engineering

C12N 15/54 Mutation or genetic engineering - Transferases (2)

Event Publications

10 September 2009 Application Open to Public Inspection

  Published as AU-A-2009210387

10 September 2009 Complete Application Filed

17 September 2009 Corrigenda

  Applications OPI - Name Index Under the name CuraGen Corporation, Application No. 2009210387, under INID (72) correct the co-inventors to Pena, Carol E. A. and Crabtree-Bokor, Julie R.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009210388-Communications jack with compensation for differential to differential and differential to common mode crosstalk

2009210386-A Platform System